Cargando…
Efficacy and safety of venous thromboembolism prophylaxis with apixaban in major orthopedic surgery
Over the last 15 years, low-molecular-weight heparins (LMWHs) have been accepted as the “gold standard” for pharmaceutical thromboprophylaxis in patients at high risk of venous thromboembolism (VTE) in most countries around the world. Patients undergoing major orthopedic surgery (MOS) represent a po...
Autores principales: | Werth, Sebastian, Halbritter, Kai, Beyer-Westendorf, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333460/ https://www.ncbi.nlm.nih.gov/pubmed/22547932 http://dx.doi.org/10.2147/TCRM.S24238 |
Ejemplares similares
-
Safety of apixaban for venous thromboembolism prophylaxis: the evidence to date
por: Trkulja, Vladimir
Publicado: (2016) -
Rivaroxaban for venous thromboembolism prevention after major orthopedic surgery: translating trial data into routine clinical practice
por: Beyer-Westendorf, Jan, et al.
Publicado: (2017) -
Venous Thromboembolism Prophylaxis in Major Orthopedic Surgeries and Factor XIa Inhibitors
por: Jones, Aaryana, et al.
Publicado: (2023) -
Venous Thromboembolism Therapy with Apixaban in Daily Care Patients: Results from the Dresden NOAC Registry
por: Beyer-Westendorf, Jan, et al.
Publicado: (2021) -
Venous thromboembolism in major lower limb orthopedic surgery
por: Kumar, Sudhir
Publicado: (2013)